Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Betta Pharma Completes $106 Million IPO in Shenzhen

publication date: Nov 7, 2016
Betta Pharma raised $106 million via an IPO on Shenzhen's Chi-Next Exchange. Formed by returnees in 2003, Betta develops and manufactures China Class 1.1 novel drugs for cancer, diabetes, cardiovascular and cerebrovascular diseases. Icotinib (Conmana) was initially approved in China in 2011, and in 2014, it added the indication for first-line use in non-small cell lung cancer. Betta's manufacturing facilities are located in Hangzhou, and it operates an R&D lab in Beijing. In the IPO, Betta was priced at a price-earnings ratio of 23 and moved 44% higher in initial trading, where it was halted, giving Betta a market capitalization of $1.3 billion. More details....

Stock Symbol: (SHZ: 300558)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here